News / Events

Recent News View All News

Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®

September 6, 2024

Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)

September 3, 2024

Recent Events View IR Calendar

Second Quarter 2024 Financial Results Conference Call

Aug 8, 2024 • 8:00 am EDT

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings